Gland Pharma Ltd. ( (IN:GLAND) ) has provided an announcement.
Gland Pharma Limited has announced the dispatch of a Notice of Postal Ballot and e-voting information, as per the SEBI regulations. This move is aimed at seeking shareholder approval for resolutions, including the grant of employee stock options under the Gland Pharma Employee Stock Option Scheme 2025. The postal ballot process will allow shareholders to vote electronically, ensuring transparency and compliance with regulatory requirements.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of complex injectables. The company is based in Hyderabad, India, and is known for its extensive portfolio of injectable products catering to various therapeutic areas.
YTD Price Performance: -14.22%
Average Trading Volume: 10,622
Current Market Cap: 266.4B INR
For an in-depth examination of GLAND stock, go to TipRanks’ Stock Analysis page.